BRIEF-Vertex Pharmaceuticals Q2 Adjusted EPS USD 4.73 Vs. IBES Estimate USD 4.73

Reuters2026/08/03 20:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Aug 03 (Reuters) - Vertex Pharmaceuticals Q2 adjusted net income USD 1,207.3 million vs. IBES estimate USD 1,229 million.

Q2 EPS USD 4.31
Q2 revenue USD 3,333.9 million vs. IBES estimate USD 3,232 million
outlook FY revenue USD 13,100-13,200 million vs. IBES estimate USD 13,065 million
Outlook FY revenue USD 13,100-13,200 million

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRIEF-Vertex Pharmaceuticals Q2 Adjusted EPS USD 4.73 Vs. IBES Estimate USD 4.73

You may also like

Crypto prices